Publications (17) View all
-
Article: A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLEEJHGOpen
Johanna K Sandling, Sophie Garnier, Snaevar Sigurdsson, Chuan Wang, Gunnel Nordmark, Iva Gunnarsson, Elisabet Svenungsson, Leonid Padyukov, Gunnar Sturfelt, Andreas J|[ouml]|nsen, [......], Anders M|[auml]|larstig, Rona J Strawbridge, Anders Hamsten, Lindsey A Criswell, Robert R Graham, Timothy W Behrens, Maija-Leena Eloranta, Gunnar Alm, Lars R|[ouml]|nnblom, Ann-Christine Syv|[auml]|nen[show abstract] [hide abstract]
ABSTRACT: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease in which the type I interferon pathway has a crucial role. We have previously shown that three genes in this pathway, IRF5, TYK2 and STAT4, are strongly associated with risk for SLE. Here, we investigated 78 genes involved in the type I interferon pathway to identify additional SLE susceptibility loci. First, we genotyped 896 single-nucleotide polymorphisms in these 78 genes and 14 other candidate genes in 482 Swedish SLE patients and 536 controls. Genes with P<0.01 in the initial screen were then followed up in 344 additional Swedish patients and 1299 controls. SNPs in the IKBKE, TANK, STAT1, IL8 and TRAF6 genes gave nominal signals of association with SLE in this extended Swedish cohort. To replicate these findings we extracted data from a genomewide association study on SLE performed in a US cohort. Combined analysis of the Swedish and US data, comprising a total of 2136 cases and 9694 controls, implicates IKBKE and IL8 as SLE susceptibility loci (Pmeta=0.00010 and Pmeta=0.00040, respectively). STAT1 was also associated with SLE in this cohort (Pmeta=3.3 × 10−5), but this association signal appears to be dependent of that previously reported for the neighbouring STAT4 gene. Our study suggests additional genes from the type I interferon system in SLE, and highlights genes in this pathway for further functional analysis.Keywords: systemic lupus erythematosus; type I interferon system; candidate gene study; single nucleotide polymorphism; IKBKE; IL8European Journal of HumanGenetics 12/2010; 19(4):479-484. · 4.40 Impact Factor -
Article: A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE.
Johanna K Sandling, Sophie Garnier, Snaevar Sigurdsson, Chuan Wang, Gunnel Nordmark, Iva Gunnarsson, Elisabet Svenungsson, Leonid Padyukov, Gunnar Sturfelt, Andreas Jönsen, [......], Anders Mälarstig, Rona J Strawbridge, Anders Hamsten, Lindsey A Criswell, Robert R Graham, Timothy W Behrens, Maija-Leena Eloranta, Gunnar Alm, Lars Rönnblom, Ann-Christine Syvänen[show abstract] [hide abstract]
ABSTRACT: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease in which the type I interferon pathway has a crucial role. We have previously shown that three genes in this pathway, IRF5, TYK2 and STAT4, are strongly associated with risk for SLE. Here, we investigated 78 genes involved in the type I interferon pathway to identify additional SLE susceptibility loci. First, we genotyped 896 single-nucleotide polymorphisms in these 78 genes and 14 other candidate genes in 482 Swedish SLE patients and 536 controls. Genes with P<0.01 in the initial screen were then followed up in 344 additional Swedish patients and 1299 controls. SNPs in the IKBKE, TANK, STAT1, IL8 and TRAF6 genes gave nominal signals of association with SLE in this extended Swedish cohort. To replicate these findings we extracted data from a genomewide association study on SLE performed in a US cohort. Combined analysis of the Swedish and US data, comprising a total of 2136 cases and 9694 controls, implicates IKBKE and IL8 as SLE susceptibility loci (P(meta)=0.00010 and P(meta)=0.00040, respectively). STAT1 was also associated with SLE in this cohort (P(meta)=3.3 × 10⁻⁵), but this association signal appears to be dependent of that previously reported for the neighbouring STAT4 gene. Our study suggests additional genes from the type I interferon system in SLE, and highlights genes in this pathway for further functional analysis.European journal of human genetics: EJHG 12/2010; 19(4):479-84. · 3.56 Impact Factor -
SourceAvailable from: autocure.org
Article: The MMP2 rs243865-T allele is not a major genetic factor for rheumatoid arthritis in the French Caucasian population.
[show abstract] [hide abstract]
ABSTRACT: The MMP2 rs243865-T allele was recently suggested to be associated with rheumatoid arthritis (RA) in a case-control study. MMP2 is a positional RA candidate gene. Our aim was to test rs243865 in a French family based study. No significant result was shown. The MMP2 rs243865-T allele is not a major rheumatoid arthritis genetic factor in this population.International Journal of Immunogenetics 05/2008; 35(2):97-9. · 1.29 Impact Factor -
SourceAvailable from: Sophie Garnier
Article: A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.
Snaevar Sigurdsson, Gunnel Nordmark, Sophie Garnier, Elin Grundberg, Tony Kwan, Olof Nilsson, Maija-Leena Eloranta, Iva Gunnarsson, Elisabet Svenungsson, Gunnar Sturfelt, Anders A Bengtsson, Andreas Jönsen, Lennart Truedsson, Solbritt Rantapää-Dahlqvist, Catharina Eriksson, Gunnar Alm, Harald H H Göring, Tomi Pastinen, Ann-Christine Syvänen, Lars Rönnblom[show abstract] [hide abstract]
ABSTRACT: Systemic lupus erythematosus (SLE) is the prototype autoimmune disease where genes regulated by type I interferon (IFN) are over-expressed and contribute to the disease pathogenesis. Because signal transducer and activator of transcription 4 (STAT4) plays a key role in the type I IFN receptor signaling, we performed a candidate gene study of a comprehensive set of single nucleotide polymorphism (SNPs) in STAT4 in Swedish patients with SLE. We found that 10 out of 53 analyzed SNPs in STAT4 were associated with SLE, with the strongest signal of association (P = 7.1 x 10(-8)) for two perfectly linked SNPs rs10181656 and rs7582694. The risk alleles of these 10 SNPs form a common risk haplotype for SLE (P = 1.7 x 10(-5)). According to conditional logistic regression analysis the SNP rs10181656 or rs7582694 accounts for all of the observed association signal. By quantitative analysis of the allelic expression of STAT4 we found that the risk allele of STAT4 was over-expressed in primary human cells of mesenchymal origin, but not in B-cells, and that the risk allele of STAT4 was over-expressed (P = 8.4 x 10(-5)) in cells carrying the risk haplotype for SLE compared with cells with a non-risk haplotype. The risk allele of the SNP rs7582694 in STAT4 correlated to production of anti-dsDNA (double-stranded DNA) antibodies and displayed a multiplicatively increased, 1.82-fold risk of SLE with two independent risk alleles of the IRF5 (interferon regulatory factor 5) gene.Human Molecular Genetics 07/2008; 17(18):2868-76. · 7.64 Impact Factor -
SourceAvailable from: Sophie Garnier
Article: Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.
Geoffrey Hom, Robert R Graham, Barmak Modrek, Kimberly E Taylor, Ward Ortmann, Sophie Garnier, Annette T Lee, Sharon A Chung, Ricardo C Ferreira, P V Krishna Pant, [......], Anders A Bengtsson, Solbritt Rantapää-Dahlqvist, Michelle Petri, Susan Manzi, Michael F Seldin, Lars Rönnblom, Ann-Christine Syvänen, Lindsey A Criswell, Peter K Gregersen, Timothy W Behrens[show abstract] [hide abstract]
ABSTRACT: Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease in which the risk of disease is influenced by complex genetic and environmental contributions. Alleles of HLA-DRB1, IRF5, and STAT4 are established susceptibility genes; there is strong evidence for the existence of additional risk loci. We genotyped more than 500,000 single-nucleotide polymorphisms (SNPs) in DNA samples from 1311 case subjects with SLE and 1783 control subjects; all subjects were North Americans of European descent. Genotypes from 1557 additional control subjects were obtained from public data repositories. We measured the association between the SNPs and SLE after applying strict quality-control filters to reduce technical artifacts and to correct for the presence of population stratification. Replication of the top loci was performed in 793 case subjects and 857 control subjects from Sweden. Genetic variation in the region upstream from the transcription initiation site of the gene encoding B lymphoid tyrosine kinase (BLK) and C8orf13 (chromosome 8p23.1) was associated with disease risk in both the U.S. and Swedish case-control series (rs13277113; odds ratio, 1.39; P=1x10(-10)) and also with altered levels of messenger RNA in B-cell lines. In addition, variants on chromosome 16p11.22, near the genes encoding integrin alpha M (ITGAM, or CD11b) and integrin alpha X (ITGAX), were associated with SLE in the combined sample (rs11574637; odds ratio, 1.33; P=3x10(-11)). We identified and then confirmed through replication two new genetic loci for SLE: a promoter-region allele associated with reduced expression of BLK and increased expression of C8orf13 and variants in the ITGAM-ITGAX region.New England Journal of Medicine 03/2008; 358(9):900-9. · 53.30 Impact Factor